The Hazards of Period Specific and Weighted Hazard Ratios-Reference-Cited by-同舟云学术

The Hazards of Period Specific and Weighted Hazard Ratios

Published:2020-06-23 Issue:4 Volume:12 Page:518-519
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Bartlett Jonathan W.¹^ORCID,Morris Tim P.²,Stensrud Mats J.³⁴,Daniel Rhian M.⁵,Vansteelandt Stijn K.⁶⁷,Burman Carl-Fredrik⁸

Affiliation:

1. Department of Mathematical Sciences, University of Bath, Bath, UK;

2. MRC Clinical Trials Unit at UCL, London, UK;

3. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts;

4. Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway;

5. Division of Population Medicine, Cardiff University, Cardiff, UK;

6. Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium;

7. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK;

8. Data Science & AI, AstraZeneca R&D Gothenburg, Goteborg, Sweden

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2020.1755722

Reference10 articles.

1. Unobserved heterogeneity: The odd effects of frailty

2. Does Cox analysis of a randomized survival study yield a causal treatment effect?

3. The Hazards of Hazard Ratios

4. ICH E9 (R1) (2019), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” available at https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample size calculation for mixture cure model with restricted mean survival time as a primary endpoint;Statistical Methods in Medical Research;2024-08-06

2. Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation method;BMC Medical Research Methodology;2024-07-30

3. Bias of the additive hazard model in the presence of causal effect heterogeneity;Lifetime Data Analysis;2024-03-11

4. Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection;Nature Communications;2024-02-26

5. A Review of Causal Inference Methods for Estimating the Effects of Exposure Change when Incident Exposure Is Unobservable;Current Epidemiology Reports;2024-02-19